Lilly Stock Faces Selling Pressure After RFK Jr.-Tied Controversy Hurts Shares
Recently, shares of Lilly stock have been under pressure due to controversy surrounding the ties between the company and Robert F. Kennedy Jr. This has led some investors to question whether it is time to sell their shares in the pharmaceutical company.
RFK Jr. has been known for his anti-vaccine views and his involvement in spreading misinformation about vaccines. This has caused concern among investors who worry about the impact of this controversy on the company’s reputation and ultimately its stock price.
While it is important to consider the potential implications of this controversy on Lilly stock, it is also important to remember that the company has a strong track record of success in the pharmaceutical industry. It is crucial for investors to weigh the risks and rewards before making any decisions about selling their shares.
Overall, the recent woes tied to RFK Jr. have rankled shares of Lilly stock, but it is ultimately up to individual investors to decide whether they believe in the long-term prospects of the company.